The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tricida, Inc. (NASDAQ: TCDA) who purchased shares between September 4, 2019 and October 28, 2020. The action, which was filed in the United States District Court for the Northern District of California, alleges that the Company violated federal securities laws.
In particular, the Tricida lawsuit alleges that (i) Tricida’s NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
Shareholders have until March 8, 2021 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
To learn more and keep informed, complete this form >